MedTrace Logo

WiseApp for Spanish Speakers Living With HIV

NCT05398185 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 248

Last updated 2026-02-27

No results posted yet for this study

Summary

This study aims to conduct a 12-month randomized controlled trial to adapt the mobile app, WiseApp, and a smart pill dispenser for Spanish-speaking people living with HIV (PLWH) in the New York City (NYC) area and La Romana, Dominican Republic (DR). The study will assess the efficacy and sustainability of WiseApp as well as identify barriers with its widespread use among Spanish speakers. With disproportionately high rates of HIV in the New York City area and the Dominican Republic, this project seeks to identify distinct contextual factors related to Spanish speaking people living with HIV and increase the likelihood of engagement with technology and improvements in clinical outcomes.

Conditions

  • HIV Infections
  • Acquired Immune Deficiency Syndrome
  • Sexually Transmitted Diseases, Viral

Interventions

DEVICE

CleverCap

The CleverCap pill bottle is an innovative technology that dispenses only the prescribed amount of medication, keeps track of medications dispensed, and communicates wirelessly with the WiseApp to deliver medication adherence reminders.

Sponsors & Collaborators

  • Clínica de Familia La Romana, Dominican Republic

    collaborator UNKNOWN

  • Columbia University

    lead OTHER

Principal Investigators

  • Rebecca Schnall, PhD, MPH · Columbia University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2026-11-01
Completion
2027-01-31
FDA Device
Yes

Countries

  • United States
  • Dominican Republic

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05398185 on ClinicalTrials.gov